Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study.

MedStar author(s):
Citation: Journal of the American College of Cardiology. 76(22):2635-2646, 2020 12 01.PMID: 33069849Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Coronary Artery Disease | *Coronary Stenosis | *Endovascular Procedures | *Equipment Design | *Lithotripsy | *Percutaneous Coronary Intervention | *Vascular Calcification | Aged | Coronary Angiography/mt [Methods] | Coronary Artery Disease/di [Diagnosis] | Coronary Artery Disease/su [Surgery] | Coronary Stenosis/dg [Diagnostic Imaging] | Coronary Stenosis/su [Surgery] | Endovascular Procedures/is [Instrumentation] | Endovascular Procedures/mt [Methods] | Female | Humans | Lithotripsy/is [Instrumentation] | Lithotripsy/mt [Methods] | Male | Percutaneous Coronary Intervention/is [Instrumentation] | Percutaneous Coronary Intervention/mt [Methods] | Severity of Illness Index | Stents | Tomography, Optical Coherence/mt [Methods] | Treatment Outcome | Vascular Calcification/dg [Diagnostic Imaging] | Vascular Calcification/su [Surgery]Year: 2020Local holdings: Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007ISSN:
  • 0735-1097
Name of journal: Journal of the American College of CardiologyAbstract: BACKGROUND: Coronary calcification hinders stent delivery and expansion and is associated with adverse outcomes. Intravascular lithotripsy (IVL) delivers acoustic pressure waves to modify calcium, enhancing vessel compliance and optimizing stent deployment.CONCLUSIONS: Coronary IVL safely and effectively facilitated stent implantation in severely calcified lesions. Copyright (c) 2020 The Authors. Published by Elsevier Inc. All rights reserved.METHODS: Disrupt CAD III (NCT03595176) was a prospective, single-arm multicenter study designed for regulatory approval of coronary IVL. The primary safety endpoint was freedom from major adverse cardiovascular events (MACE: cardiac death, myocardial infarction or target vessel revascularization) at 30 days. The primary effectiveness endpoint was procedural success. Both endpoints were compared to a pre-specified performance goal (PG). The mechanism of calcium modification was assessed in an optical coherence tomography (OCT) sub-study.OBJECTIVE: To assess the safety and effectiveness of IVL in severely calcified de novo coronary lesions.RESULTS: Patients (n=431) were enrolled at 47 sites in four countries. The primary safety endpoint of the 30-day freedom from MACE was 92.2%; the lower bound of the 95% confidence interval (CI) was 89.5% which exceeded the PG of 84.4% (P<0.0001). The primary effectiveness endpoint of procedural success was 92.4%; the lower bound of the 95% CI was 90.2% which exceeded the PG of 83.4% (P<0.0001). Mean calcified segment length was 47.9+/-18.8 mm, calcium angle was 292.5+/-76.5degree and calcium thickness was 0.96+/-0.25 mm at the site of maximum calcification. OCT demonstrated multi-plane and longitudinal calcium fractures after IVL in 67.4% of lesions. Minimum stent area was 6.5 +/- 2.1mm2 and was similar regardless of demonstrable fractures on OCT.All authors: Bachinsky W, Herrmann HC, Hill JM, Kereiakes DJ, Klein AJ, Price MJ, Riley RF, Shlofmitz RA, Stone GW, Waksman ROriginally published: Journal of the American College of Cardiology. 2020 Oct 10Fiscal year: FY2021Digital Object Identifier: Date added to catalog: 2020-12-29
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 33069849 Available 33069849

Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007

BACKGROUND: Coronary calcification hinders stent delivery and expansion and is associated with adverse outcomes. Intravascular lithotripsy (IVL) delivers acoustic pressure waves to modify calcium, enhancing vessel compliance and optimizing stent deployment.

CONCLUSIONS: Coronary IVL safely and effectively facilitated stent implantation in severely calcified lesions. Copyright (c) 2020 The Authors. Published by Elsevier Inc. All rights reserved.

METHODS: Disrupt CAD III (NCT03595176) was a prospective, single-arm multicenter study designed for regulatory approval of coronary IVL. The primary safety endpoint was freedom from major adverse cardiovascular events (MACE: cardiac death, myocardial infarction or target vessel revascularization) at 30 days. The primary effectiveness endpoint was procedural success. Both endpoints were compared to a pre-specified performance goal (PG). The mechanism of calcium modification was assessed in an optical coherence tomography (OCT) sub-study.

OBJECTIVE: To assess the safety and effectiveness of IVL in severely calcified de novo coronary lesions.

RESULTS: Patients (n=431) were enrolled at 47 sites in four countries. The primary safety endpoint of the 30-day freedom from MACE was 92.2%; the lower bound of the 95% confidence interval (CI) was 89.5% which exceeded the PG of 84.4% (P<0.0001). The primary effectiveness endpoint of procedural success was 92.4%; the lower bound of the 95% CI was 90.2% which exceeded the PG of 83.4% (P<0.0001). Mean calcified segment length was 47.9+/-18.8 mm, calcium angle was 292.5+/-76.5degree and calcium thickness was 0.96+/-0.25 mm at the site of maximum calcification. OCT demonstrated multi-plane and longitudinal calcium fractures after IVL in 67.4% of lesions. Minimum stent area was 6.5 +/- 2.1mm2 and was similar regardless of demonstrable fractures on OCT.

English

Powered by Koha